UTILIZATION OF ATOMOXETINE AND OTHER PHARMACOTHERAPY IN YOUTHS WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER IN MEDICAID PATIENTS IN 29 US STATES

被引：0
|
作者：
Linden, S. [1 ]
Knox, C. [1 ]
Winterstein, A. [1 ]
机构：
[1] Univ Florida, Gainesville, FL 32610 USA
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 2011年 / 173卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S132 / S132
页数：1
相关论文
共 50 条
  • [1] Atomoxetine Utilization in Youths with Attention Deficit/Hyperactivity Disorder in 29 Medicaid States
    Linden, Stephan
    Knox, Caitlin
    Winterstein, Almut G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S134 - S134
  • [2] Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in medicaid database
    Winterstein, Almut G.
    Gerhard, Tobias
    Shuster, Jonathan
    Zito, Julie
    Johnson, Michael
    Liu, Huazhi
    Saidi, Arwa
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (01) : 24 - 31
  • [3] Combined methylphenidate and atomoxetine pharmacotherapy in attention deficit hyperactivity disorder
    Ozbaran, Burcu
    Kose, Sezen
    Yuzuguldu, Onur
    Atar, Burcu
    Aydin, Cahide
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2015, 16 (08): : 619 - 624
  • [4] Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in Taiwan
    Wang, Liang-Jen
    Yang, Kang-Chung
    Lee, Sheng-Yu
    Yang, Chun-Ju
    Huang, Ting-Shuo
    Lee, Tung-Liang
    Yuan, Shin-Sheng
    Shyu, Yu-Chiau
    PLOS ONE, 2016, 11 (08):
  • [5] Pharmacotherapy of attention deficit hyperactivity disorder
    Spencer, T
    Biederman, J
    Wilens, T
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2000, 9 (01) : 77 - +
  • [6] Comparative Efficacy of Methylphenidate and Atomoxetine on Social Adjustment in Youths with Attention-Deficit/Hyperactivity Disorder
    Shang, Chi-Yung
    Shih, Hsien-Hsueh
    Pan, Yi-Lei
    Lin, Hsiang-Yuan
    Gau, Susan Shur-Fen
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020, 30 (03) : 148 - 158
  • [7] ASSESSING THE ECONOMIC BURDEN AND HEALTH CARE UTILIZATION OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER AMONG MEDICAID PATIENTS IN THE UNITED STATES
    Zhang, Q.
    Zhao, Y.
    Keshishian, A.
    Xie, L.
    Yuce, H.
    Baser, O.
    VALUE IN HEALTH, 2016, 19 (03) : A187 - A187
  • [8] Atomoxetine for the treatment of attention-deficit/hyperactivity disorder
    Davids, E
    Gastpar, M
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2004, 72 (10) : 586 - 591
  • [9] Atomoxetine for Attention Deficit Hyperactivity Disorder in Mental Retardation
    Fernandez-Jaen, Alberto
    Martin Fernandez-Mayoralas, Daniel
    Calleja Perez, Beatriz
    Munoz Jareno, Nuria
    Campos Diaz, Maria del Rosario
    PEDIATRIC NEUROLOGY, 2010, 43 (05) : 341 - 347
  • [10] Atomoxetine treatment of attention-deficit/hyperactivity disorder
    Eiland, LS
    Guest, AL
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (01) : 86 - 90
12345